Syros Pharmaceuticals
Redefining the power of small molecules to control gene expression and to provide a profound benefit for patients. Learn more
Launch date
Employees
Market cap
$52.3m
Enterprise valuation
$34m (Public information from Sep 2024)
Share price
$1.98 SYRS
Watertown Massachusetts (HQ)
Authorizing premium user...